Pharmaceuticals News
Browse the latest Pharmaceuticals news. Use the menu or navigation tiles to change industry or topic.
-
Akciju sabiedrības „GRINDEKS” (vienotais reģ. nr. 40003034935, juridiskā adrese: Krustpils iela 53, Rīga, LV-1057) valde sasauc un paziņo, ka akciju sabiedrības „GRINDEKS” kārtējā akcionāru sapulce...
-
Notification on convocation of joint stock company “GRINDEKS” Annual General Meeting of shareholders
The Management Board of joint stock company “GRINDEKS” (registration number: 40003034935, legal address: 53 Krustpils street, Riga, Latvia, LV-1057) calls up and announces that Annual General Meeting...
-
SALT LAKE CITY, May 02, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical...
-
VANCOUVER, British Columbia, May 02, 2019 (GLOBE NEWSWIRE) -- via NetworkWire: Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the “Company”) is excited to announce the signing of an agreement with...
-
EASTPHARMA LTD. London, 02 May 2019 - EastPharma (EAST LI), today announces that the Annual General Meeting is to be held at 10.00 am on 29 May 2019 at Clarendon House, 2 Church Street, Hamilton...
-
Active Biotech (NASDAQ, STOCKHOLM:ACTI) announce that the Election Committee of Active Biotech AB (publ) proposes that Michael Shalmi and Uli Hacksell are appointed new members of the Board of...
-
BEDMINSTER, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that it has been invited to ring...
-
BASKING RIDGE, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
-
NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and...
-
BOSTON, May 02, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that...
Healthcare Providers News
Browse the latest Healthcare Providers news. Use the menu or navigation tiles to change industry or topic.
Medical Equipment News
Browse the latest Medical Equipment news. Use the menu or navigation tiles to change industry or topic.
Medical Supplies and Services News
Browse the latest Medical Supplies and Services news. Use the menu or navigation tiles to change industry or topic.
Biotechnology News
Browse the latest Biotechnology news. Use the menu or navigation tiles to change industry or topic.
Cannabis Producers News
Browse the latest Cannabis Producers news. Use the menu or navigation tiles to change industry or topic.